Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Esperion Theraptc
(NQ:
ESPR
)
2.090
UNCHANGED
Streaming Delayed Price
Updated: 4:15 PM EDT, Apr 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
104,445
Open
2.090
Bid (Size)
2.080 (55)
Ask (Size)
2.100 (466)
Prev. Close
2.090
Today's Range
2.090 - 2.090
52wk Range
0.7000 - 3.400
Shares Outstanding
28,277,493
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Esperion to Report First Quarter 2024 Financial Results on May 7
April 23, 2024
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
Applied Digital Reports Downbeat Results, Joins Nurix Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
April 12, 2024
U.S. stock futures were mixed this morning, with the Dow futures gaining over 50 points on Friday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Performance
YTD
-28.42%
-28.42%
1 Month
-20.23%
-20.23%
3 Month
-1.88%
-1.88%
6 Month
+156.63%
+156.63%
1 Year
+71.31%
+71.31%
More News
Read More
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 11, 2024
Via
Benzinga
Earnings Scheduled For February 27, 2024
February 27, 2024
Via
Benzinga
Earnings Preview: Esperion Therapeutics
February 26, 2024
Via
Benzinga
Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
April 08, 2024
Via
Benzinga
Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (bempedoic acid) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with Obesity
April 07, 2024
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday
April 03, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 03, 2024
Via
Benzinga
Exposures
Glyphosate
Esperion to Ring Nasdaq Opening Bell Today, April 1, 2024
April 01, 2024
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
Esperion to Participate in 23rd Annual Needham Virtual Healthcare Conference
March 26, 2024
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
Esperion Announces Data from CLEAR Outcomes Sub-Groups as Poster Presentations, Moderated Session & Industry Expert Theatre to be Presented at ACC.24
March 25, 2024
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
Why Is Heart Disease-Focused Esperion Therapeutics Stock Trading Higher On Monday?
March 25, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 25, 2024
Via
Benzinga
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 25, 2024
Via
Benzinga
Why Salarius Pharmaceuticals Shares Are Trading Higher By Around 31%; Here Are 20 Stocks Moving Premarket
March 25, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
March 25, 2024
Via
InvestorPlace
Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session
March 25, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
U.S. FDA Approves Broad New Labels for Esperion’s NEXLETOL® and NEXLIZET® to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use
March 22, 2024
From
Esperion Therapeutics
Via
Business Wire
U.S. FDA Approves Broad New Labels for NEXLETOL® and NEXLIZET® to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use
March 22, 2024
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
CHMP Issues Positive Opinions For Both Bempedoic Acid And The Bempedoic Acid / Ezetimibe Fixed-Dose Combination Tablet As Treatments For Hypercholesterolemia And Significantly Reducing Cardiovascular Events
March 22, 2024
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
Esperion Reports Fourth Quarter and Full Year 2023 Financial Results
February 27, 2024
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
February 16, 2024
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
Esperion to Report Fourth Quarter and Full Year 2023 Financial Results on February 27
February 13, 2024
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
RFK, Esperion Therapeutics Announce 2024 Promotional Schedule
February 01, 2024
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.